Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Deferred Taxes (2019 - 2022)

Pulmonx (LUNG) has disclosed Deferred Taxes for 4 consecutive years, with -$49000.0 as the latest value for Q4 2022.

  • On a quarterly basis, Deferred Taxes fell 388.24% to -$49000.0 in Q4 2022 year-over-year; TTM through Dec 2022 was -$49000.0, a 916.67% decrease, with the full-year FY2024 number at $50000.0, up 308.33% from a year prior.
  • Deferred Taxes was -$49000.0 for Q4 2022 at Pulmonx, down from $17000.0 in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $17000.0 in Q4 2021 to a low of -$49000.0 in Q4 2022.
  • A 4-year average of -$10555.6 and a median of -$10000.0 in 2021 define the central range for Deferred Taxes.
  • Peak YoY movement for Deferred Taxes: surged 241.67% in 2021, then plummeted 388.24% in 2022.
  • Pulmonx's Deferred Taxes stood at -$30000.0 in 2019, then soared by 60.0% to -$12000.0 in 2020, then soared by 241.67% to $17000.0 in 2021, then tumbled by 388.24% to -$49000.0 in 2022.
  • Per Business Quant, the three most recent readings for LUNG's Deferred Taxes are -$49000.0 (Q4 2022), $17000.0 (Q4 2021), and -$1000.0 (Q2 2021).